The effect of Th2 cells in colorectal cancer is ambiguous; thus, elucidating the precise function of Th2 responses in colorectal cancer will facilitate the development and evaluation of novel cancer immunotherapeutics targeting SETD2 in Tregs. This evidence concerns the gene SETD2 and colorectal cancer.